Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001271097-03-000003
Filing Date
2003-12-01
Accepted
2003-12-01 16:10:00
Documents
2
Period of Report
2003-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2083
3 EDGAR SUPPORTING DOCUMENT poa-attiyeh.txt EX-24 3100
  Complete submission text file 0001271097-03-000003.txt   6994
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 233 KANSAS ST EL SEGUNDO CA 90245 3107268000
ATTIYEH ROBERT S (Reporting) CIK: 0001271097 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 031030238